New Paradigms in the Prevention and Treatment of Migraine with HT1F Agonist and mAb Against CGRP Pathway or its Receptor

Complimentary

Released on 11/25/19
Expires on 11/25/20

Categories: , , , , , , , , , , ,
Illustration of CGRP receptor with antibodies binding on the cell membrane.

Start Activity

Program Description

This webcast is intended to improve care of patients with migraine by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

Intended Audience

This webcast is designed to meet the educational needs of neurologists, internal medicine, family medicine physicians, nurse practitioners, physician assistants, nurses and allied healthcare professionals involved in the diagnosis and treatment of patients with migraine.

Commercial Supporters

Supported by Amgen and Alder Biopharmaceuticals, Inc.

Educational Objectives

As a result of participating in the activity, learners should be better able to:

  • Summarize the current understanding of pathophysiology of migraine and mechanism of action of serotonin and CGRP pathways
  • Identify HT 1F agonist and mAb of CGRP or its receptors based therapies for the prevention and treatment of migraine

Accredited Providers

Jointly provided by Amedco and MedNet


AMA PRA Category 1 Credit(s)™

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and MedNet. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Designation Statement

Amedco LLC designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Contact Hour(s)

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and MedNet. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Designation Statement

Amedco LLC designates this enduring activity for a maximum of 1.00 contact hour. Learners should claim only the credit commensurate with the extent of their participation in the activity.

Additional Credit Information

Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education (ACCME). or a recognized state medical society. PAs may receive a maximum of 1.00 AMA PRA Category 1 Credit™ for completing this activity.

Note to Nurse Practitioners: The American Academy of Nurse Practitioners Certification Board (AANPCB) recognizes the ACCME and the American Nurses Credentialing Center (ANCC) as approved accreditors and allows reciprocity for AANPCP continuing education credit.

Planners’ and Managers’ Disclosures

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME webcast:

Stewart J. Tepper, MD, listed his disclosures under the Faculty heading above.

Kamatham A. Naidu, PhD (MedNet, LLC), has no relevant financial relationships to disclose.
Brian Waggoner (MedNet, LLC), has no relevant financial relationships to disclose.
Sheryl Morgan (Amedco), has no relevant financial relationships to disclose.

Conflict of Interest Disclosure Policy

It is the policy of the Amedco to ensure activity content is balanced, independent, objective and based on scientific best-evidence. All persons in a position to control content (i.e., course director, planning committee member and speaker) were required to disclose any relevant financial relationship with a commercial entity relative to the content of his/her presentation.

Every person in a position to control content reported he/she does not have any relevant financial relationships with industry (relative to the content of his/her presentation) to disclose.

Disclosure of Unlabeled Use

It is the policy of the Amedco to inform each speaker of his/her responsibility to disclose to the attendees when products or procedures discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved) and of any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.

Each speaker reported he/she will notify the audience if/when discussion includes off-label, unlabeled, experimental, and/or investigational (not FDA approved) information or limited use references within the content of his/her presentation.

Disclaimer

The information provided at this educational initiative is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

NON-ENDORSEMENT OF PRODUCTS
Amedco does not imply either real or implied endorsement of any product, service, or company referred to in this educational activity.

Faculty

Stewart J. Tepper, MD
Director
Dartmouth Headache Center
Professor of Neurology
Geisel School of Medicine at Dartmouth
Hanover, New Hampshire

Dr. Tepper discloses that he research grants (no personal compensation from these research grants): Alder, Allergan, Amgen, Eli Lilly, Satsuma, Teva, Zosano; and served as consultant for Acorda, Alder, Allergan, Amgen, Aralez Canada, Axsome Therapeutics, Biohaven, Charleston Labs, Dr. Reddy’s, GSK, Eli Lilly, Impel, Novartis, Pfizer, Reckner Healthcare, Satsuma, Sorrento, Teva, XOC, Zosano.

Instructions

There are no fees for participating and receiving CME credit for this webcast. During the period November 25, 2019 through November 25, 2020, participants must read all the material and study the educational webcast.

This webcast includes text, graphics, and may include multimedia features.

To obtain credit, a score of 80% or above on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact the CME/CE Provider at 651-789-3730.

If you have any other questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

Privacy Policy

Amedco observes privacy and confidentiality of CME information and personal information of CME participants. Third parties receive only aggregated data about CME activities that are relevant to their interests and/or the activities they support.

myCME privacy policy

Video

Time to Complete: 1 hour

Released: November 25, 2019

Expires: November 25, 2020

Maximum Credits:
1.00 / AMA PRA Category 1 CreditTM
1.00 / CNE Contact Hour

Related products